JP2007518424A5 - - Google Patents

Download PDF

Info

Publication number
JP2007518424A5
JP2007518424A5 JP2006551422A JP2006551422A JP2007518424A5 JP 2007518424 A5 JP2007518424 A5 JP 2007518424A5 JP 2006551422 A JP2006551422 A JP 2006551422A JP 2006551422 A JP2006551422 A JP 2006551422A JP 2007518424 A5 JP2007518424 A5 JP 2007518424A5
Authority
JP
Japan
Prior art keywords
nucleotide
buffer
nucleotide triphosphate
replacing
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006551422A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007518424A (ja
JP2007518424A6 (ja
JP4866248B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/002414 external-priority patent/WO2005070027A2/en
Publication of JP2007518424A publication Critical patent/JP2007518424A/ja
Publication of JP2007518424A6 publication Critical patent/JP2007518424A6/ja
Publication of JP2007518424A5 publication Critical patent/JP2007518424A5/ja
Application granted granted Critical
Publication of JP4866248B2 publication Critical patent/JP4866248B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006551422A 2004-01-23 2005-01-21 核酸増幅性能改良のための新規ヌクレオチド混合物 Expired - Fee Related JP4866248B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US53881604P 2004-01-23 2004-01-23
US53881504P 2004-01-23 2004-01-23
US53881404P 2004-01-23 2004-01-23
US60/538,815 2004-01-23
US60/538,814 2004-01-23
US60/538,816 2004-01-23
PCT/US2005/002414 WO2005070027A2 (en) 2004-01-23 2005-01-21 A novel nucleotide mixture for improved nucleic acid amplification performance

Publications (4)

Publication Number Publication Date
JP2007518424A JP2007518424A (ja) 2007-07-12
JP2007518424A6 JP2007518424A6 (ja) 2007-10-11
JP2007518424A5 true JP2007518424A5 (enExample) 2008-03-06
JP4866248B2 JP4866248B2 (ja) 2012-02-01

Family

ID=34812082

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2006551422A Expired - Fee Related JP4866248B2 (ja) 2004-01-23 2005-01-21 核酸増幅性能改良のための新規ヌクレオチド混合物
JP2006551423A Pending JP2007518425A (ja) 2004-01-23 2005-01-21 Ｈｃｖ３’非翻訳領域を効率的に増幅および検出するためのプライマーおよびプローブの設計

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2006551423A Pending JP2007518425A (ja) 2004-01-23 2005-01-21 Ｈｃｖ３’非翻訳領域を効率的に増幅および検出するためのプライマーおよびプローブの設計

Country Status (6)

Country Link
US (3) US20060003343A1 (enExample)
EP (3) EP1721015B1 (enExample)
JP (2) JP4866248B2 (enExample)
AT (3) ATE417938T1 (enExample)
DE (3) DE602005023586D1 (enExample)
WO (2) WO2005071117A2 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008134374A1 (en) * 2007-04-27 2008-11-06 Eragen Biosciences, Inc. Materials and methods for detection of hepatitis c virus
JP2009284896A (ja) * 2007-07-26 2009-12-10 Fujifilm Corp 核酸増幅方法
EP2058406A3 (en) * 2007-11-06 2009-10-28 Fujifilm Corporation RNA detection method
RU2011132045A (ru) * 2008-12-31 2013-02-10 Эбботт Лэборетриз Праймеры и зонды для детектирования вируса гепатита с

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09107970A (ja) * 1995-10-17 1997-04-28 Soyaku Gijutsu Kenkyusho:Kk Ｃ型肝炎ウイルス由来核酸、該核酸を用いたウイルスの検出方法
DE3164463D1 (en) * 1980-11-12 1984-08-02 Mitsubishi Chem Ind Glutamine derivatives usable for curing immune diseases, methods for their preparation and compositions comprising said derivatives
US5087565A (en) * 1984-07-02 1992-02-11 Du Pont Merck Pharmaceutical Company Synthetic process for preparation of 32 P-labeled nucleotides
JPH0723393B2 (ja) * 1985-05-15 1995-03-15 アモコ・コーポレーション シチジン同族体
US4876187A (en) 1985-12-05 1989-10-24 Meiogenics, Inc. Nucleic acid compositions with scissile linkage useful for detecting nucleic acid sequences
US5032511A (en) * 1987-03-31 1991-07-16 Mitsubishi Kasei Corporation DNA fragments coding for antigens specific to non-A non-B hepatitis, expression vectors containing said DNA fragments, transformants and process for producing said antigens
FI891436L (fi) 1987-07-31 1989-03-23 Univ Leland Stanford Junior Selektivt flerfaldigande av targetpolynukleotidsekvenser.
US5714596A (en) * 1987-11-18 1998-02-03 Chiron Corporation NANBV diagnostics: polynucleotides useful for screening for hepatitis C virus
US5712088A (en) * 1987-11-18 1998-01-27 Chiron Corporation Methods for detecting Hepatitis C virus using polynucleotides specific for same
US5698390A (en) * 1987-11-18 1997-12-16 Chiron Corporation Hepatitis C immunoassays
US5030557A (en) 1987-11-24 1991-07-09 Ml Technology Venture Means and method for enhancing nucleic acid hybridization
JP2650159B2 (ja) 1988-02-24 1997-09-03 アクゾ・ノベル・エヌ・ベー 核酸増幅方法
CA2020958C (en) * 1989-07-11 2005-01-11 Daniel L. Kacian Nucleic acid sequence amplification methods
CA2025536C (en) 1989-09-18 1995-04-18 Hiroshi Nakagomi Ink jet recording head and ink jet recording apparatus having same
WO1991012342A1 (en) * 1990-02-16 1991-08-22 F. Hoffmann-La Roche Ag Improvements in the specificity and convenience of the polymerase chain reaction
CA2135073C (en) 1992-05-06 2002-11-19 Daniel L. Kacian Nucleic acid sequence amplification method, composition and kit
US5648232A (en) * 1993-01-21 1997-07-15 The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland Microbiological best method and reagents
CA2184270C (en) * 1994-03-10 1999-08-17 Daniel Louis Kacian Method for suppressing inhibition of enzyme-mediated reactions by ionic detergents
US6127116A (en) * 1995-08-29 2000-10-03 Washington University Functional DNA clone for hepatitis C virus (HCV) and uses thereof
US5874565A (en) * 1995-08-29 1999-02-23 Washington University Nucleic acids comprising a highly conserved novel 3 terminal sequence element of the hepatitis C virus
DE19612779A1 (de) 1996-03-29 1997-10-02 Boehringer Mannheim Gmbh Verfahren zur spezifischen Vervielfältigung von langen Nukleinsäuren durch PCR
EP2264045B1 (en) * 1996-08-14 2015-10-21 Life Technologies Corporation Stable compositions for nucleic acid amplification and sequencing
DE19647055A1 (de) * 1996-11-14 1998-05-20 Boehringer Mannheim Gmbh Stabilisierte wässrige Nukleosidtriphosphat-Lösungen
WO1998044161A1 (en) * 1997-04-03 1998-10-08 Life Technologies, Inc. Compositions and methods for reverse transcriptase-polymerase chain reaction (rt-pcr)
ZA989950B (en) * 1997-11-17 1999-05-04 Akzo Nobel Nv Transcription based amplification of double stranded DNA targets
JP2002512791A (ja) * 1998-04-27 2002-05-08 リボザイム・ファーマシューティカルズ・インコーポレーテッド Ｃ型肝炎ウイルス感染に関連する疾患または状態の酵素的核酸治療
WO2000000638A2 (en) * 1998-06-26 2000-01-06 Akzo Nobel N.V. Tagging of rna amplicons generated by transcription-based amplification
US6300075B1 (en) * 1999-02-03 2001-10-09 Ortho-Clinical Diagnostics, Inc Enhancement of the specificity of nucleic acid amplification by carrier nucleic acid
US6638714B1 (en) * 1999-02-03 2003-10-28 Ortho-Clinical Diagnostics, Inc. Oligonucleotide primers for efficient detection of hepatitis C virus (HCV) and methods of use thereof
DE60034884T2 (de) * 1999-06-04 2008-01-17 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Klonierte genome von infektiösen hepatitis c viren genotyp 2a und deren verwendungen
US6271004B1 (en) * 1999-06-25 2001-08-07 Display Systems Biotech A/S Method for improved reverse transcription at high temperatures
EP1233976A4 (en) * 1999-11-17 2003-06-11 Jiuping Ji SIMULTANEOUS DETECTION OF HBV, HCV AND HIV IN PLASMA SAMPLES WITH THE AID OF A MULTIPLEX FIXING TEST
AU2001254670A1 (en) * 2000-03-02 2001-09-12 Akzo Nobel N.V. Detection of hepatitis b virus rna
CA2442092A1 (en) * 2001-03-26 2002-10-17 Ribozyme Pharmaceuticals, Inc. Oligonucleotide mediated inhibition of hepatitis b virus and hepatitis c virus replication
WO2003016572A1 (en) * 2001-08-17 2003-02-27 Eli Lilly And Company Oligonucleotide therapeutics for treating hepatitis c virus infections
US6783940B2 (en) 2001-10-31 2004-08-31 Applera Corporation Method of reducing non-specific amplification in PCR
US6750009B2 (en) * 2002-01-29 2004-06-15 Apath, Llc Multiple viral replicon culture systems
WO2003100014A2 (en) * 2002-05-24 2003-12-04 Smithkline Beecham Corporation Method for quantitating negative strand rna synthesis

Similar Documents

Publication Publication Date Title
JP2008245635A5 (enExample)
GT200500053S (es) Botella
MEP44608A (en) Methods for treating infectious disease exacerbated asthma
SG10201408300PA (en) Processing of amplified dna fragments for sequencing
BRPI0714876A2 (pt) glucanases, ácidos nucleicos codificando as mesmas e métodos para fabricar e usar as mesmas.
TWI319718B (en) Hydrogen-producing fuel processing assemblies, heating assemblies, and methods of operating the same
ME02268B (me) POSTUPAK ZA DOBIJANJE MODIFIKOVANIH ELEKTRODA, ELEKTRODE DOBIJENE TIM POSTUPKOM I ENZIMATSKI BIOSENZORl KOJI SADRŽE TE ELEKTRODE
EP4435100A3 (en) Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
EP1899800A4 (en) ETL DIAGRAM AND TOOL FOR STRUCTURED AND UNSTRUCTURED DATA
WO2006135684A3 (en) Methods and kits for sense rna synthesis
PL1937834T3 (pl) Sposoby wzmacniania, kwantyfikacji i identyfikacji kwasów nukleinowych
JP2009504138A5 (enExample)
NO20082240L (no) GLP-2 imitatorstoff, polypeptider, sammensetninger, fremgangsmater og anvendelser
EP2055789A4 (en) PRIMER SET FOR THE REINFORCEMENT OF THE CYP2C19 GENE, REAGENT FOR THE REINFORCEMENT OF THE CYP2C19 GENE THEREFOR AND APPLICATION THEREOF
EA200701742A1 (ru) Способы получения сиропа
BRPI0517131A2 (pt) mÉtodos para simplificar Ácidos nuclÉicos microbiais por modificaÇço quÍmica de citosinas
JP2009520748A5 (enExample)
EP2116598A4 (en) Novel Beta GALACTOSIDE ALPHA-2,6-SIALYLTRANSFERASE, GENE FOR THEIR CODING AND METHOD FOR INCREASING ENZYMATIC ACTIVITY
EP2055775A4 (en) PRIMER ASSEMBLY FOR AMPLIFYING THE CYP2C9 GENE, A REAGENT FOR CYP2C9 GENE AMPLIFICATION, AND USE THEREOF
JP2008542528A5 (enExample)
JP2007518424A5 (enExample)
EP2029723A4 (en) TFLA-GEN, which may lead to the degradation of toxoflavin and its chemical derivatives, as well as the transgene-expressing transgenic organism
ZA200805382B (en) Keratin-binding effector molecules, and method for the production thereof
JP2010528630A5 (enExample)
EP2055774A4 (en) PRIMER SET FOR THE REINFORCEMENT OF THE SULT1A1 GENE, REAGENT FOR THE REINFORCEMENT OF THE SULT1A1 GENIUS THEREFOR AND APPLICATIONS THEREOF